INDV
Indivior Pharmaceuticals, Inc.
36.00$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.1% | -3.1% | +5.3% | +2.7% | -2.6% | -11.0% | +13.5% | +4.0% | +14.0% | -11.5% | +8.2% | – | |
| – | +10.9% | -25.5% | +107.9% | -12.7% | -66.7% | +91.3% | +18.2% | +19.2% | +3.2% | -37.5% | +22.5% | – | |
| – | +7.6% | +1.7% | -10.6% | +8.2% | +16.0% | -19.6% | +12.6% | +0.8% | +16.7% | -5.8% | +6.1% | – | |
| – | +61.1% | -3.4% | -7.1% | -15.4% | +40.9% | -29.0% | -4.5% | -4.8% | -15.0% | -5.9% | -25.0% | – | |
| – | -77.2% | -13.5% | +97.4% | +36.8% | +45.2% | -78.5% | +143.1% | -1.9% | +43.9% | -44.4% | -1.6% | – | |
| – | -55.6% | -5.5% | +97.7% | -30.8% | -23.1% | -13.3% | +14.1% | -14.0% | +12.4% | -18.6% | -4.3% | – | |
| – | – | +23.0% | -257.3% | – | +2,300.0% | -31.3% | +9.1% | +37.5% | +23.2% | +12.3% | +16.8% | – | |
| – | -10.0% | -11.1% | +12.5% | +11.1% | +30.0% | -7.7% | +25.0% | -20.0% | -50.0% | +16.7% | -71.4% | – | |
| – | – | +17.7% | -265.8% | – | – | -33.0% | +5.1% | -40.3% | +118.9% | +42.0% | +39.1% | – | |
| – | – | +37.5% | -309.1% | – | – | -60.7% | +300.0% | -111.4% | – | – | +46.2% | – | |
| – | – | +13.0% | -259.0% | – | +1,375.0% | -20.3% | -61.7% | +133.3% | +142.9% | -12.7% | +37.1% | – | |
| – | – | +10.1% | -221.8% | – | +381.8% | -28.3% | +7.9% | -34.1% | +70.4% | +34.8% | +30.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.